Solid lipid magnetic resonance nanoparticle as well as preparation method and application thereof
A nanoparticle and solid lipid technology, applied in emulsion delivery, drug delivery, etc., can solve problems such as weak affinity, achieve low toxicity, high cell survival rate, and solve the problem of burst release
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0031] Example 1: Preparation of Gd-DTPA-loaded solid lipid nanoparticles
[0032] (1) First, weigh 54mg Tween-80 dissolved in 3ml water to form the water phase, 600mg Span-80 dissolved in 30ml n-hexane to form the organic phase, add the water phase to the organic phase under stirring conditions at room temperature at 400rpm. Probe ultrasound to prepare submicroemulsion;
[0033] (2) Then weigh 62.6 mg of gadopentetate meglumine and dissolve it in water to obtain an aqueous solution. Dissolve 18 mg of octadecylamine in 3 ml of ethanol to obtain an ethanol solution, and then combine the two at 60°C for 30 min, and spin at 60°C under vacuum. The solvent is evaporated to obtain an intermediate product;
[0034] (3) Add 3ml ethanol, 90mg monoglyceride and 10mg lecithin mixture to the intermediate product prepared in step (2), inject it into the submicroemulsion prepared in step (1) under heating at 60°C, stir at room temperature for 5 minutes; then centrifuge at 20,000 rpm After 20 min...
Example Embodiment
[0035] Example 2: Investigation of the physical and chemical properties of Gd-DTPA-loaded solid lipid nanoparticles
[0036] The solid lipid nanoparticles prepared above were taken, ultrapure water was used as the resolvent, and the particle size was measured with a 3000HS particle size and surface potential analyzer at a concentration of 0.01 mg / ml.
[0037] The indirect method was used to determine the encapsulation efficiency of Gd-DTPA in solid lipid nanoparticles. Fluorescence spectrophotometry (Ex=495nm, Em=514nm, Slit=5nm) was used to measure the fluorescence value, calculate the amount of free Gd-DTPA in the solution, and calculate the encapsulation rate of the fluorescent graft according to formula (1):
[0038] Gd-DTPA encapsulation rate = (Wo-W free) / Wo*100% (1)
[0039] The drug loading of Gd-DTPA is calculated according to formula (2):
[0040] Gd-DTPA drug loading=(additional drug*encapsulation rate) / (additional drug*encapsulation rate+carrier material dosage)*100%
[0041...
Example Embodiment
[0043] Example 3: In vitro drug release behavior of Gd-DTPA-loaded solid lipid nanoparticles
[0044] Pipette a certain volume of SLN solution, place it in a dialysis bag (MWCO 3.5KDa), and then put it into a release tube containing 25ml of release medium (pH 7.2PBS). In vitro release was performed under constant temperature shaking at 37°C and 65 rpm, and samples were taken at specific time points (0.5h, 1h, 2h, 4h, 6h, 8h, 12h, 24h, 36h, 48h and 72h), and all release media were replaced at the same time. Measure the drug concentration in the sample by fluorescence spectrophotometry (Ex=275nm, Em=313nm, slit=5nm, working voltage=700V), and calculate the cumulative release and cumulative release percentage of the drug. The result is image 3 Shown.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap